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Abstract 
AIM: To determine the association of H pylori CagA+ 
infection and pro-inflammatory polymorphisms of the 
genes interleukin (IL)-1RN and IL-1B with the risk of 
gastric atrophy and peptic ulcers in a dyspeptic popu-
lation in Costa Rica, a country with high incidence and 
mortality of gastric cancer. 
METHODS: Seven biopsy specimens, a fasting blood 
sample and a questionnaire concerning nutritional and 
sociodemographic factors were obtained from 501 con-
secutive patients who had undergone endoscopy for 
dyspeptic symptoms. A histopathological diagnosis was 
made. Pepsinogen concentrations were analyzed by 
enzyme linked immunosorbent assay (ELISA). Infection 
with H pylori CagA+ was determined by serology and 
polymerase chain reaction (PCR). IL-1B and IL-1RN 
polymorphisms genotyping was performed by PCR-
restriction fraament lenath polymorphism (PCR-RFLP)  
and PCR respectively. 
RESULTS: In this dyspeptic population, 86% were 
H pylori positive and of these, 67.8% were positive for 
CagA. Atrophic antral gastritis (MG) was associated 
with CagA+ status [odd ratio (OR) = 4.1; P < 0.000] 
and fruit consumption (OR = 0.3; P < 0.00). Atrophic 
body gastritis (ABG) was associated with pepsinogen 
PGI/PGII < 3.4 (OR = 4.9; P < 0.04) and alcohol 
consumption (OR = 7.3; P < 0.02). Duodenal ulcer 
was associated with CagA+ (OR = 2.9; P < 0.04) and 
smoking (OR = 2.4; P < 0,04). PGI < 60 j.tg/L as well 
as PGI/PGII < 3.4 were associated with CagA+, 
CONCLUSION: In a dyspeptic population in Costa Rica, 
H pylori CagA* is not associated with ABG, but it is a 
risk factor for MG. The pro-inflammatory cytokine poly-
morphisms 1L-1B + 3945 and IL-1RN are not associated 
with the atrophic lesions of this dyspeptic population. 
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INTRODUCTION 
Colonization with H pylori is associated with atrophic 
gastritis, peptic ulcer and distal gastric canceril'21. Never-
theless, many colonized individuals never develop these 
pathologies. Genetic characteristics of the host and the 
bacteria as well as environmental factors may be involved 
in the final clinical outcomel31. The pathogenicity and 
virulence of H pylori increases when the infecting strain 
expresses the casA gene that codes for a highly immuno-
genic protein Cae-A. which is a marker for the Presence 
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of the cag pathogenicity island (PAI)1451. Moreover, the 
immune response of the host is considered a key event 
in the pathogenic process that leads to gastric cancer. A 
number of studies have reported that carriers of certain 
alleles in genes encoding proinflammatory and anti-
inflammatory cytokines exhibit a stronger inflammatory 
response against H pylon and a marked inhibition of acid 
secretion resulting in an increased risk of gastric cancer 
and its precursors, atrophic gastritis and intestinal meta-
plasia'6'71. However, this association has not been found 
in all studied populadonel. 
The development of atrophic gastritis is central in 
the multi-step process which leads to gastric cancer and 
the risk increases with the severity and physical extension 
of the atrophic lesion19"1. Serum levels of pepsinogen 
(PGI) and the ratio of PGI/PGII serum levels decrease 
significantly with increased extension and severity of 
atrophic gastritis and gastric cancer. Therefore these pa-
rameters have been proposed as serological markers for 
those histopathological changesili-13i. Costa Rica is one 
of the countries with the highest incidence and mortal-
ity rates of gastric cancer worldwide. The prevalence of 
II pylori associated gastritis is high from an early age". 
Recently, we found an association between the 
PGI/PGII ratio and atrophic body gastritis in dyspeptic 
patients'151. In the present study, the same population 
was analyzed for associations of atrophic body and an-
tral gastritis and presence of peptic ulcers with H pylori 
Cag.A.  infection and pro-inflammatory interleukin-1 
(IL-1) gene polymorphisms. 
MATERIALS AND METHODS 
Patients 
As previously described1151, between January and July 
2000, 800 consecutive patients referred to the endoscopy 
service at the Calderon Guardia Hospital in San Jose for 
dyspeptic symptoms were interviewed. This hospital is 
a tertiary hospital that, however, also provides gastroen-
terology service at primary and secondary levels. Patients 
were excluded if they were under 18 years of age, had 
not resided in Costa Rica for the previous two years, had 
received H pylori eradication therapy, had taken antibi-
otics during the 3 mo preceding endoscopy, had taken 
bismuth compounds at the time of endoscopy, had a 
history of gastric surgery, suffered from diseases associ-
ated with coagulation, or presented digestive bleeding. 
A total of 501 patients fulfilled the inclusion criteria and 
signed an informed consent form before 25 mL of fast-
ing blood was obtained. The project had been previously 
approved by the ethic committees of the University of 
Costa Rica and the Hospital. A questionnaire with in-
formation concerning sociodemographic factors, family 
history, general health status, consumption of salt, cof-
fee, alcohol, fruit, vegetables, and smoking habits was 
filled out1151. Blood pressure and height and weight were 
recorded to calculate the body mass index. 
Endoscopy procedure 
Seven biopsies were obtained: two biopsies from the  
middle part of the antrum were taken from the major 
and minor curvatures and two from the gastric body at 
the anterior and posterior walls of the central body for 
histopathological diagnosis. One biopsy from the antrum 
and one from the body were taken for culture and one 
from the antrum for rapid crease test". 
Histological diagnosis 
Sections of formaline-fixed and paraffin-embedded bi-
opsies, stained with haematoxylin and eosin, were used 
for the histopathological diagnosis according to the 
Sydney Classification' 61. All slides were independently 
read by two specialists in gastric pathology QA Ramirez 
in San Jose, Costa Rica, and A De Mascarel in Bordeaux, 
France). Cases with discrepant diagnoses were reviewed 
by both pathologists until a consensus was reached. A 
patient was considered to have: (1) Atrophic body gastri-
tis (ABG), if atrophy or metaplasia was present in any of 
the biopsies from the body; (2) Atrophic antral gastritis 
(AAG), when atrophy was found in any of the biopsies 
from the antrum and not in the body; (3) Non-atrophic 
gastritis (NAG), in the case of gastritis without atrophy 
or normal mucosa, when no pathology was found in the 
antrum or the body and no granulocytic activity or lym-
phoid follicles were observed. In 22% of the patients, 
there was not histopathological diagnosis because there 
was not sufficient tissue in the biopsies". 
H pylori status 
Infection with H pylori was determined by histology, cul-
ture and serology. For histological detection, the slides 
were stained with tolouidine blue. One biopsy from the 
antrum and one from the body were cultured for H 
Biopsies from the antrum and corpus were ground in bru-
cella broth with an electric homogenizer. The suspensions 
were plated on two in-house media: a Wilkins Chalgren 
agar containing 10% human blood and antibiotics and a 
Columbia blood agar without antibiotics incubated for 10 
d in a microaerohic atmosphere at 37.C. Standard identi-
fication was performed. Serum antibodies to Hpyloti were 
measured by an in-house enzyme linked immunosorbent 
assay pi ISA) developed in our laboratory and based on a 
modification of a previously described ELISA'171. The an-
tigen preparation and determination of cutoff points was 
previously reported'''. A patient was considered positive 
for H pylori when positive by any of the three methods: 
culture or histology or serology and negative when none 
of the methods were positive. 
CagA status 
The cagA status was determined by polymerase chain 
reaction (PCR) on isolated strains using primers cagAi-A, 
and, if negative, a second set of primers, cagA3-A4. were 
used'''. Serum antibodies to CagA were measured by 
ELISA as described by Blaser et al, 1995". A patient was 
considered positive for H pylori CagA{  infection when 
positive by PCR and/or serology. 
Serum pepsinogen concentrations 
The concentrations of PGI and PGII in sera were 
measured by an enzyme immunosorbent assay (EAI) 
(Eiken Chemical Company, Tokyo, Japan) according to 
the manufacturer's recommendations. The validation of 
pepsinoen levels for this population was described pre-
viously° I. In order to detect as many patients as possible 
with ABG, a cut-off point that favored sensitivity was 
selected. The optimal cut-off point for this population 
had been set at a PGI/PGII ratio of 3.4, which gave a 
sensitivity of 91.2% and a specificity of 38.5%4151. The 
predictive value for a positive sample was 11.2% and for 
a negative 98.1%. Pepsinogen levels could not be mea-
sured in 51% patients because insufficient amounts of 
blood were obtained or because the patients did not ac-
cept being bled. 
1L-1B and 1L-!RN genotyping 
IL-1B polymorphism analysis was performed by PCR-
restriction fragment length polymorphism (PCR-RFLP). 
100 ng of genomic DNA were amplified with the prim-
ers and PCR conditions previously reported12°I . The PCR 
products for IL-1B + 3954 were digested with the re-
striction enzyme Taql and the allele designation for this 
polymorphism was the same as previously reported". 
Genomic DNA (100 ng) was amplified using the 
same primers and PCR conditions as previously report-
ed for IL-/RNI2°I. For statistical analysis purposes and 
because of the low frequency of alleles 3, 4 and 5, this 
polymorphism was treated as biallelic by dividing alleles 
into short and long categories, in which the short allele 
has two repeats (allele 2) and long allele has more than 
two repeats (allele L). For 110 (22%) patients genotyping 
was not done because of insufficient leukocyte samples 
or problems in the isolation or analysis of the DNA. 
Statistical analysis 
x2 statistics were used for comparing genotype frequen-
cies among the groups studied and to assess Hardy-
Weinberg equilibrium for each of the loci studied. Allelic 
frequencies were assessed using Estimating Haplotype 
Frequencies (EH) (available at ftp://linkage.rockefeller. 
edu/ software/ eh/). Politomic logistic regression was 
used to compare genotypic frequencies among the 
groups studied here using STATA/SE 8.0 (STATA Cor-
poration, College Station, TX). 
A logistic regression model was used to calculate 
the odd ratios (ORs) for (dependent variable): (1) ABG 
compared to dyspepsia without atrophic gastritis; (2) 
AAG compared to dyspepsia without atrophic gastri-
tis; (3) Gastric ulcer compared to all of the others; (4) 
Duodenal ulcer compared to the rest; (5) Levels of PGI 
< 60 pg/L compared to levels of PGI > 60 pg/L; and 6) 
Values of PGI/PGII < 3.4 compared to values of PGI/ 
PGII > 3.4. The systematic independent variables were 
Hpy/oti CagA infection, IL-1B + 3954 allele T carriers, 
IL-1RN allele 2 carriers, and those that had been associ-
ated with the dependent variables in a previous study of 
the same population: age, sex, overweight, frequency of 
alcohol and fruit consumption and the PGI/PGII ratio 
for atrophic gastritis and age; gender and cigarette smok-
ing for penile ulcers1151. The logistic regression analyses 
Sex (M/F) Age (yr), PGI (mg/L), PGI/PGII, 
(a 155/324) mean mean mean 
(95% CI) (95% CO (95% CO 
Normal 9/12 38 (30.745.7) 39.7 (27.9-51.5) 4.3 (3.3-5.4) 
NAG 104/225 45 (43.2-46.6) 53.1 (49.4-56.9) 3.3 (3.1-3.6) 
AAG 26/67 50 (47.0-52.8) 60.2 (52.9-67.5) 3.3 (2.9-3.7) 
ABG 16/20 53 (48.2-57.6) 36.1(26,6-45.5)' 1.9 (1.5-2.4)' 
'P S 0.001, ABG vs the rest. 
were performed including either, only H pylori infected 
individuals or, all of the participants. The association 
was determined as an OR at a confidence interval of 
95%. Statistical significance was set at P < 0.05. The 
software STATA/SE 8.0 (STATA Corporation, College 
Station, TX) was used for the statistical analysis. 
RESULTS 
In this study, 501 patients were included, 338 women 
with an average age of 46.3 years and 163 men with an 
average age of 46 years. The mean age was higher in 
groups with the most severe pathologies (Table 1). 
Pepsinogen 
PGI y PGII concentrations could be measured in 479 
patients. Serum concentrations of PGI as well as the 
PGI/PGII ratio were lower in patients with ABG as 
compared to other dyspeptic patients (Table 1). Dyspeptic 
patients with a ratio below 3.4 were at increased risk of 
having ABG compared to those with a ratio higher than 
3.4 (Table 2). 
H pylori CagA' 
The frequency of H pylori infection was 86%, out of 
which 67.8% were CagA+, however the prevalence varied 
according to the pathology. Patients with a normal his-
topathological diagnosis, although few, showed a lower 
incidence of infection with H pylori and Hpy/on.  CagA+ 
(15.0% and 5.3% respectively) as compared to the rest, 
NAG (88.9% and 55.5%), AAG (93.3% and 81.6%) or 
ABG (82.9% and 58.8%). The prevalence of infection 
with H pylori and H pylori CagA+ for gastric ulcer was 
l00% and 52.2% respectively, and for duodenal ulcer 
98% and 85% respectively. Among patients with PGI/ 
PGII < 3.4, the prevalence of infection with H pylori 
was 87.7% and with H pylori CagA+ 61.3% while that 
of patients with ratios > 3.4 were at 82.1% and 50.0%. 
H pylori CagA+ was associated with a PGI/PGII ratio < 
3.4 and PGI < 60 pg/L (Table 3). 
Polymorphisms: 1L-1RN and 11.-1B + 3954 
Genotyping of the cytokine polymorphisms was suc-
cessfully performed in 371 patients (74%). Genotypic 
distributions of IL-1RN and IL-1B + 3954 polymor-
phisms were not significantly different among the 
studied p-rouns (Table 41. There was Hardv-Weinbery 
Atrophic gastritis 
In AAG 
Atrophic gastrkk 
In body (ABG) 
OR 95% CI P OR 95% CI P 
Age > 50 yr 16 0.8-3.0 0.2 2.8 1.0-7.7 0.04 
Men 0.6 0.3-1.2 0.2 1.2 0.4-3.5 0.7 
Overweight (BMI > 25.9) 0.7 0.3-1.2 0.2 0.8 0.3-2.0 0.6 
Fruit consumption 
0-1 times/wk 1.0 1.0 
2-6 times/wk 0.4 0.2-0.8 0.01 1.4 0.4-4.6 0.6 
More than 6 times/ wk 0.3 0.2-0.7 0.00 0.7 0.2-2.6 0.6 
Alcohol consumption 
No consumption 1.0 1.0 
Weekends or more 3.0 0.8-12 0.1 7.3 1.5-35.8 0.02 
H pylori 
CagA status' 4.1 1.9-9.0 0.000 1.2 0.4-3.5 0.7 
IL-113 + 3954 
T carriers vs CC 0.6 0.3-1.2 0.16 0.9 0.3-2.4 0.8 
IL-1RN 
2 carriers vs LL 1.4 0.8-2.6 0.3 1.3 0.5-3.5 0.6 
PGI/PGII < 3.4 1.4 0.7-2.8 0.3 4.9 1.1-22.5 0.04 
`Logistic regression, AAG and ABC vs non-atrophic gastritis. 
Normal NOAG AAG ABG 
11-1RN 
11/17 (65) 
6/17 (35) 
124/253 (49) 
107/253 (42) 
33/76 (43) 
31/76 (41) 
13/25 (52) 
8/25 (32) 
2.2 0/17 (0) 22/253 (9) 12/76 (16) 4/25 (16) 
Allelic freq. 2 0.16 0.27 0.29 0.28 
IL-1B + 3954 
CC 12/18 (66) 123/250 (49) 46/77 (60) 13/26 (50) 
CT 5/18 (28) 121/250 (48) 30/77 (39) 13/26 (50) 
TT 1/18 (6) 6/250 (3) 1/77 (1) 0/26 (0) 
Allelic freq. T 0.22 0.26 0.20 0.24 
Gastric uker Duodenal ulcer 
OR 95% CI P OR 95% CI 	 P 
Age > 50 yr 3.3 1.2-9.1 0.02 0.8 0.4-1.8 0.6 
Men 0.3 0.9-1.3 0.1 3.2 1.5-7.2 0.004 
Present smoker 1.2 0.3-4.7 0.8 2.4 1.0-5.6 0.04 
H pylon 
CagA status' 0.7 0.3-1.8 0.4 2.9 1.0-7.9 0.04 
1L-1B + 3954 
T carriers vs CC 1.2 0.5-3.2 0.7 0.9 0.4-1.9 0.8 
IL-1RN 
2 carriers vs LL 1.4 0.5-3.6 0.5 0.7 0.3-1.4 0.3 
PGI < 60 j.tg/L PGI/PGII < 3.4 
OR 95% CI P OR 95% CI P 
Age > 50 y r 1.1 0.6-1.8 0.8 1.6 1.0-2.7 0.07 
Men 1.6 0.9-2.7 0.09 0.7 0.4-1.2 0.2 
Overweight (BNB > 25.9) 1.0 0.6-1.7 0.9 0.6 0.4-1.0 0.04 
Fruit consumption 
0-1 times/wk 1.0 1.0 
2-6 times/ wk 0.6 0.3-1.2 0.1 1.6 0.9-2.8 0.1 
More than 6 times/wk 1.3 0.7-2.4 0.4 1.3 0.7-2.4 0.4 
Alcohol consumption 
No consumption 1.0 1.0 
Weekends or more 0.2 0.05-1.1 0.07 1.8 0.5-6.3 0.3 
H pylori 
CagA status* 2.5 1.4-4.3 0.002 1.8 1.1-3.0 0.03 
IL-1B + 3954 
T carriers vs CC 1.2 0.7-1.9 0.5 0.8 0.5-1.3 0.3 
IL-1RN 
2 carriers vs LL 1.6 1.0-2.7 0.06 0.9 0.6-1.4 0.3 
`Logistic regression, PO < 60 µg/L vs PGI > 60 µg/L and PO/MR < 3.4 
vs PGI/PGII < 3.4. 
equilibrium for the IL-1RN locus in the groups used 
here as controls (dyspepsia without atrophic gastritis and 
all of the groups together excluding ABG). However, 
in the case of the IL-1B + 3954 polymorphism, there 
was no equilibrium for any of the control groups (data 
not shown). The frequency of the allele 2 for IL-1RN 
polymorphism was not significantly different in normal 
patients compared to those with some type of gastritis 
(Table 4). 
Logistic regression atrophic gastritis 
An increased risk of ABG was observed among patients 
'Logistic regression, Peptic ulcer vs no peptic ulcer. 
older than 50 years, those consuming alcohol and those 
with a PGI/PGII ratio < 3.4. Patients infected with 
CagA+ strains of H pylori and those with lower consump-
tion of fruit were at higher risk of developing AAG, 
(Table 2). The presence of pro-inflammatory alleles, IL-
IB + 3954T and IL-RN*2, did not confer an enhanced 
risk of any type of atrophy (Table 2). 
Peptic ulcers 
Duodenal ulcer was more frequent than gastric ulcer 
(52/24), in both genders. However, it was twice as com-
mon in males and the average age of patients with duo-
denal ulcer (average 46; 95% IC, 42.5-50.2) was lower 
than that of those with gastric ulcer (average 58; 95% 
CI, 52.2-63.6). Males, smokers and patients infected with 
H pylori CagA+ were at increased risk of duodenal ulcer 
(Table 5). 
DISCUSSION 
While NAG associated with H pylori is more prevalent in 
industrialized countries, atrophic gastritis is more com-
mon in the developing world. The reason for this is prob-
ably a combination of effects caused by H pylon and other 
infections in early childhood, as well as other environmen-
tal factors and genetic composition14'221. Atrophic gastritis 
initiates in the antrum and may extend upwards towards 
the gastric body, often resulting in more severe atrophic 
gastritis with increased agem . It has been reported in sev- 
eral studies that infection with H pylori CagA+  increases 
the risk of atrophic gastritis and gastric cancer14:231. In the 
present study, infection with H pylori CagA + is associ-
ated with atrophic gastritis of the antrum but not of the 
body, results which are in accordance with those reported 
by Oksanen et al, 20001241. Indeed, in a stomach affected 
by ABG, the microenvironment is more hostile for the 
survival and growth of H pylon promoting spontaneous 
eradication of the bacteria and a progressive decline in 
concentrations of serum antibodies to H pylons -21. Atro-
phic gastritis has been considered as a consequence of 
prolonged gastritis caused by H pylori and the association 
between H pylori infection and gastric cancer appears stron-
ger when the infection is recorded several years before the 
onset of cancer1214. Therefore, in our study, the associa-
tion of H pylori CagA+ with ABG may be underestimated 
taking into account that patients belong to a population 
in which Hpy/ori-associated gastritis is prevalent from 
childhood". H pylori and its virulence factor CagA may 
be involved in processes during the early stages of inflam-
mation of the antrum that lead to extension of atrophic 
gastritis towards the gastric bodyl291. 
In concordance with other studies, infection with 
H pylori-CagA+ is associated with low PGI/PGII 
rados1241. Several studies have reported an association of 
low PGI concentrations and low PGI/PGII ratios with 
precancerous lesions as well as with gastric caneerl3"2). 
In the study population, PGI/PGII values below 3.4 
were previously shown to be associated with ABG but 
not with AAG1131. The studies performed in Costa Rica 
to date indicate low specificities of the pepsinogen test 
for the detection of gastric cancer and ABG (64% and 
38.5% respectively). Nevertheless, its high negative 
predictive values (99.5% and 98%) could make the 
PG rest useful to eliminate, from subsequent steps of 
screening programs, persons that are unlikely to develop 
gastric cancer) 5'331. 
Our results fail to demonstrate an association be-
tween AAG, ABG and pro-inflammatory polymor-
phisms IL-1B + 3945 or IL-1RN. The control group 
consisted of dyspeptic patients of which a large majority 
suffered from some inflammatory condition (NAG). In 
a previous study, performed by our group, among partic-
ipants in a program at the Center for Early Detection of 
Gastric Cancer in Costa Rica, it was found that IL-1B + 
3945T and IL-1RN*2 were associated with an increased 
risk of gastric cancer: OR = 3, P = 0.007 and OR = 2.9; 
P = 0.03 respectively1341. In this study, the control groups 
were normal individuals as judged by X-ray (double con-
trast, gastric study). 
The combination of IL-1B + 3954 and IL-1RN pro-
inflammatory genotypes, or that of proinflammatory 
alleles and CagA, did not reveal any association with any 
particular pathology when included in the logistic regres-
sion analysis (data not shown). 
Recent reports concerning the association of poly-
morphisms enhancing the expression of the gene IL-1B 
with atrophic gastritis, gastric cancer and peptic ulcer, 
diverge in their resultel. Several studies link these poly-
mornhisms to a reduction in acid secretion, gastric in- 
flammation, atrophy, and gastric cancer16.2(''36381, whereas 
others do not139 421. These contradictory results may be 
related to the characteristics of the studied population, 
the methodology used, regional differences with regard 
to the frequencies of pro- or anti-inflammatory poly-
morphisms, the prevalence and time of infection with 
H pylori and the characteristics of the infecting strain as 
well as diet and other environmental factors that interact 
with and influence the final result of the pathological 
process initiated by the infection143-451. 
The results of the present study show that consump-
tion of fruit, even in modest quantities, diminishes the 
risk of AAG but has no effect on more advanced at-
rophy, ABG. It has been suggested that the protective 
properties of fruit are due to its content of antioxidants 
that would counteract the oxidative stress induced by 
Hpy/ot71"1. 
The data presented here are in accordance with re-
ports from other laboratories stating that CagA+ individ-
uals are at higher risk of developing duodenal ulcers147'481. 
Although patients with duodenal ulcer have reduced risk 
of gastric cancer, H pylori predisposes to both condi-
done'. These different consequences may be a result of 
the host response to the infection. It has been reported 
that an increase in acidity predispose for duodenal ulcer-
ation whereas hypochlorhydia is associated with a higher 
risk of developing gastric cancerm. 
In summary, this study does not permit the conclu-
sion that there exists no association between infection 
with CagA+ H pylori and ABG because H pylori is spon-
taneously eradicated with the severity and extension of 
atrophic lesions. Future epidemiologic investigations 
should eliminate the inherent biases of sub-detection 
of H pylori and specially H pylori CagA+. The true re-
lationships between H pylori and diseases of the upper 
gastrointestinal tract are highly complex. It is of crucial 
importance to identify the factors that direct the initial 
inflammatory reactions to different gastric pathologies 
and decipher the mechanisms involved those processes, 
not only for the understanding of carcinogenesis but 
also for the prevention and detection of diseases related 
to Hpy/ori. 
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